KIEFFER TARA LYNN (Sr. VP, New Product Dev.) reported 1 transaction at ENANTA PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 12/3/2025ACC: 0002064832-25-000046
Officer· Sr. VP, New Product Dev.
Since Dec 2020
-753.00
Net shares
Net seller
$10.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
753.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−753.00
Price / share
$14.12
Trade value
$10.63K
% of position
2.2%
12/1/2025
33.48K→32.73K
Total
Net shares
−753.00
Net value
-$10.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2025 | F · Tax Withholding | −753.00 | $14.12 | $10.63K | 2.2% | 33.48K | 32.73K |
| Total | −753.00 | -$10.63K | ||||||
Derivative Transactions0
No derivative transactions reported